A Phase I, Single-Blind, Randomised, Placebo-Controlled, 5 Period Cross-Over Study to Determine the Effect of Pre-Treatment with Oral or Intravenous Anti-Emetic on the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose of AZD5438 in Healthy Male Volunteers

Study identifier:D0110C00008

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase I, Single-Blind, Randomised, Placebo-Controlled, 5 Period Cross-Over Study to Determine the Effect of Pre-Treatment with Oral or Intravenous Anti-Emetic on the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose of AZD5438 in Healthy Male Volunteers

Medical condition

solid tumour

Phase

Phase 1

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Dec 2004
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

-

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria